She received a state-of-the-art bio-implant that has miraculously regulated the condition with minimal invasiveness — and ...

One successful initiative in this field is the project of Kish Tissue Regeneration Corporation, which has played a key role in bio-implant development, supported by IDRO. This technology is currently ...

Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ETCompany ParticipantsLouisa Smith - The Gilmartin GroupAntony Koblish ...

Explore why INmune Bio, Inc. is a speculative Strong Buy for high-risk investors. Click for the upcoming catalysts that make ...

Discover the top 4 undervalued Health Care Equipment & Supplies stocks for Tuesday, May 06 based on AAII’s Stock Grades.

Korro Bio, Inc. announced an interim readout from its Phase 1/2a clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) is expected in the second half of 2025, with trial completion ...

Here’s how a bio implant stopped Long Island woman’s ‘horrific’ arthritis in its tracks: ‘This is the future’ ...

The EV maker has already posted weaker-than-expected Q1 deliveries and analysts polled by Visible Alpha expect quarterly adjusted earnings per share (EPS) to have fallen by nearly 8% year-over ...

The tech titan reported revenue increased 13% year-over-year to $70.07 billion and profit of $3.46 per share, both above Visible Alpha consensus. Intelligent Cloud segment revenue jumped 21% to $ ...

PETALING JAYA: Bioalpha Holdings Bhd has proposed a RM110mil reduction of its issued share capital as part of a house keeping exercise of its balance sheet. In a filing with Bursa Malaysia ...